[Technical support and the immunization program performance in Côte d'Ivoire]

Sante Publique. 2019 January-February;Vol. 31(1):177-186. doi: 10.3917/spub.191.0177.
[Article in French]

Abstract

Objective: The objective of this study is to analyze the effect of a technical support aiming to improve vaccine program performance in the 10 health districts (HDs) of Côte d'Ivoire, in which the largest numbers of children not vaccinated against measles were registered.

Method: These HDs benefited between June 2016 and May 2017, from four quarterly supportive supervisions along with technical support in health logistics and data management and quality. We had followed the evolution of the key indicators in each targeted HD and compared them to the other HDs.

Results: The measles containing vaccine coverage (MCVC) had increased and exceeded 80% in 8 out of 10 the targeted HDs. The increase of this MCVC was higher in the targeted HDs (12 points versus 3 points). The number of children not vaccinated against measles had been reduced by 66% and in 8 out of 10 HDs. The global drop-out rate decreased by 13 points in the targeted HDs, whereas it increased by 1 point in the other HDs.The timeliness increased and was more than 80% in 9 of the 10 targeted HDs. The increase of this timeliness was better in the targeted HDs (35 points versus 25 points). The overall quality index was higher in the targeted HDs (90% versus 82%) and the score per component for targeted HDs was better.

Conclusion: This technical support has have an positive effect on the vaccine performance of targeted HDs. The current challenge is to scale up this type of intervention to all districts in the country.

MeSH terms

  • Child
  • Cote d'Ivoire / epidemiology
  • Humans
  • Immunization Programs / methods
  • Immunization Programs / organization & administration*
  • Mass Vaccination / methods
  • Mass Vaccination / organization & administration*
  • Mass Vaccination / statistics & numerical data
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage*
  • Program Evaluation

Substances

  • Measles Vaccine